In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register.
about
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Biomarkers predicting a need for intensive treatment in patients with early arthritisRecommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy.Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
P2860
In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In patients with early inflamm ...... he Norfolk Arthritis Register.
@ast
In patients with early inflamm ...... he Norfolk Arthritis Register.
@en
type
label
In patients with early inflamm ...... he Norfolk Arthritis Register.
@ast
In patients with early inflamm ...... he Norfolk Arthritis Register.
@en
prefLabel
In patients with early inflamm ...... he Norfolk Arthritis Register.
@ast
In patients with early inflamm ...... he Norfolk Arthritis Register.
@en
P2860
P50
P356
P1476
In patients with early inflamm ...... the Norfolk Arthritis Register
@en
P2093
David G I Scott
Diane K Bunn
P2860
P304
P356
10.1136/ARD.2010.148106
P407
P577
2011-05-08T00:00:00Z